Patient Resources
Get Healthy!
GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls
- June 25, 2026
- HealthDayTV HealthDay Reporter
A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.
Health News is provided as a service to Cayucos Pharmacy site users by HealthDay. Cayucos Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.
